fertiShare Evaluation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCardiff University

About this trial

Sharing bad news (SBN) is a daily challenge for fertility staff and patients. Bad news happens at all stages of fertility care and includes e.g., diagnosing infertility, reporting unexpected, repeated, or definitive treatment failure. Extensive evidence shows that SBN triggers stress in staff due to anticipation of negative emotions and evaluations or, in extreme cases, even complaints and lawsuits. Inability to manage bad news can increase negative emotions in patients and fuel distrust, potentially leading to treatment discontinuation. Efficient SBN training exists but does not address challenges of SBN in fertility care, does not meet fertility staff training and patient care preferences, and its impact on patients is unclear.

fertiShare is a brief, evidence-based, e-Learning SBN course bespoke for fertility care. The aim of the study is to evaluate the feasibility of implementing fertiShare at fertility clinics and of implementing an online multi-centre RCT to determine fertiShare's efficacy. This will allow to conclude if fertiShare should proceed to efficacy evaluation.

An international interdisciplinary stakeholder group (patients, consultants, embryologists, nurses, psychologists, digital educators) will inform all aspects of the proposed project.

Eligibility criteria

Qualifiers

working at participating clinics; and

whose role involves a minimum of 10% of week time (half a day) SBN or being a non-clinical decision-maker (e.g., clinic/line managers).

Disqualifiers

not being able to read, speak or understand English;

not being able to provide consent.

for FHPs only, being unable to undergo the fertiShare training (e.g., visual impairments).

Trial design

Treatments tested in this trial

  • fertiShare intervention - sharing bad news eLearning course
  • fertiShare control - basic communication skills eLearning course

Treatment groups

420 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Cardiff University

Lead sponsor

Wales Fertility Institute, Swansea Bay University Healthboard, Wales, UK

Collaborator

Dept of Health Sciences, Milan University, Milan, Italy

Collaborator